OR WAIT null SECS
Empire Genomics (Buffalo, New York, USA) has announced that it has chosen Funakoshi as a distributor of its product portfolio for the Japanese market.
Empire Genomics (Buffalo, New York, USA) has announced that it has chosen Funakoshi as a distributor of its product portfolio for the Japanese market. The deal highlights Empire's international expansion and growth in the region.
Anthony Johnson, President and CEO of Empire Genomics, commented, “We are excited to have such a proven and expert partner in Funakoshi to service our Japanese customers and offer access to our broad genomic product and service portfolio. I am confident this relationship will provide customers with the excellent support and high quality service our customers have come to expect.”
Dr Ryoya Funakoshi, President and CEO of Funakoshi Company, Ltd., said, “We are delighted with Empire Genomics’ agreement. Empire Genomics perfectly complements our portfolio range of high-quality products and services. The Empire Genomics portfolio provides Funakoshi Company the opportunity to meet high demands for basic bioscience research and also for the pharmaceutical research in Japan.”
For more information please visit ref="http://www.empiregenomics.com">www.empiregenomics.com